Abstract
Dermatomyositis and polymyositis may affect children and adults and are now widely recognized as major causes of disability which, thanks to the introduction of immunosuppressive drugs, is often treatable, at least to some extent. Few data exist regarding polymyositis in elderly patients. We describe a case of refractory life-threatening polymyositis in an elderly patient, successfully treated with intravenous cyclophosphamide. Copyright © by Biolife, s.a.s.
Author supplied keywords
Cite
CITATION STYLE
Pinto, A., Tuttolomondo, A., Di Raimondo, D., Di Gati, M., Di Sciacca, R., Fernandez, P., & Licata, G. (2006). Successful “salvage” therapy of intravenous cyclophosphamide for refractory polymyositis in an elderly patient: Case report. International Journal of Immunopathology and Pharmacology, 19(4), 929–934. https://doi.org/10.1177/039463200601900424
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.